Skip to content

ASND

Ascendis Pharma A/S

Stock

$227.87+0.56 (+0.25%)Close Oct 2, 2026

Operating income, 2025
−€136M

Operating income

Operating income by fiscal year

PeriodOperating incomeYoY
2025−€136M—
2024−€279M—
2023−€456M—
2022−€562M—
2021−€452M—
2020−€331M—
2019−€227M—
2018−€155M—
2017−€112M—
2016−€73M—
2015−€42M—